The core activity of CROSS Research SA is the conduct of clinical trials, particularly Phase I trials, for the pharmaceutical industry. The company offers services such as central clinical laboratories, analytical laboratories for drug analysis and pharmaceutical laboratories for the development of drugs. It also conducts safety studies, dose-finding studies, bioavailability and bioequivalence studies, as well as specialized studies such as skin adhesion studies and medical device testing.